• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

    5/23/24 7:00:45 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Cusack Catherine

    (Last) (First) (Middle)
    C/O SABRA HEALTH CARE REIT, INC.
    1781 FLIGHT WAY

    (Street)
    TUSTIN CA 92782

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Sabra Health Care REIT, Inc. [ SBRA ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/22/2024 P 7,000 A $14.43 46,385(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Includes 1,014 unvested stock units and 33,371 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
    Remarks:
    /s/ Michael Costa, as Attorney-in-Fact 05/23/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SBRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    12/5/2024$20.00Outperform → Neutral
    Mizuho
    10/1/2024$16.00 → $20.00Equal Weight → Overweight
    Wells Fargo
    9/13/2024$17.00 → $20.00Neutral → Buy
    Citigroup
    1/30/2024$21.00Buy
    Deutsche Bank
    10/17/2023$16.00Outperform → Market Perform
    BMO Capital Markets
    10/16/2023$13.00 → $15.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $SBRA
    SEC Filings

    See more
    • SEC Form 144 filed by Sabra Health Care REIT Inc.

      144 - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      5/15/25 4:10:13 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Sabra Health Care REIT Inc.

      10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:06:34 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:05:31 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sabra Health Care REIT downgraded by Truist

      Truist downgraded Sabra Health Care REIT from Buy to Hold

      1/17/25 11:05:39 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT upgraded by JMP Securities with a new price target

      JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00

      1/7/25 8:27:55 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT downgraded by Mizuho with a new price target

      Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00

      12/5/24 8:19:25 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    See more
    • Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

      Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

      1/4/24 9:15:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

      1/12/21 9:05:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Ann Kono to Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M

      12/21/20 9:00:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      2/25/25 5:04:04 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/23/24 7:00:45 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      10/18/24 11:35:05 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 5:13:53 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 2:19:42 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    See more
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl

      2/19/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2025 Investor Conference and Attend ASHA's 2025 Mid-Year Meeting

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2025 Investor Conference June 2 – 5, 2025 at the New York Hilton Midtown in New York, New York. Additionally, Talya Nevo-Hacohen, Darrin Smith, and other members of the company, will attend ASHA's 2025 Mid-Year Meeting on June 9 – 10, 2025, at the Omni Interlocken Hotel, in Broom

      5/22/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Foster Michael J sold $200,376 worth of shares (11,000 units at $18.22), decreasing direct ownership by 15% to 64,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/22/25 2:55:39 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Porter Clifton J Ii was granted 855 shares, increasing direct ownership by 2% to 48,721 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:49:21 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Malehorn Jeffrey A. was granted 946 shares, increasing direct ownership by 1.00% to 95,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:48:55 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate